As L&D Intern in Indonesia, you will help colleagues build the skills they need to perform at their best. You will coordinate learning activities, work with digital learning platforms and AI tools, and use participation data to show what works. Your work connects learning to performance and business outcomes, so people can grow with Novo and make a greater impact for people living with serious chronic diseases.
Previous experience in an HR, learning or training environment, for example through a university project, a student organisation or earlier internship.
You will support the delivery of learning that helps people and teams in Indonesia move from intention to action.
You will join People & Organisation (P&O) in Indonesia, where colleagues work across markets to serve people around the world and help improve health at scale.
Day to day, you will partner with employees, line managers, facilitators and external vendors. Clear communication and quick follow-up will keep programmes on track, so you will often be the person who brings people and priorities together.
You will work on live learning programmes and build new skills in learning coordination, data analysis, digital learning and AI. You will see how your work supports performance across the business, and be supported to learn as you go.
You will be trusted to take ownership, make your voice heard and grow with every project.
Your impact begins today. If you are ready to help colleagues learn, grow and perform at their best, apply for the L&D Intern role by 30 November 2026. Applications are reviewed on an ongoing basis, so we encourage you to apply as soon as possible.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html